$AGN Recent Headlines U.K. stocks advance, but
Post# of 74544
Posted On: 05/02/2014 10:13:42 AM
$AGN Recent Headlines
U.K. stocks advance, but Shire loses grip of gains 12:29 p.m. April 29, 2014 - Carla Mozee
Allergan looks for white knight to counter Valeant's hostile bid: reports 11:10 a.m. April 29, 2014 - blogs.marketwatch.com
Allergan looks to Sanofi, J&J for takeover: report 9:48 a.m. April 29, 2014 - Karen Friar
Allergan preparing to approach Shire: report 4:23 p.m. April 28, 2014 - MarketWatch.com
AstraZeneca jumps, leading U.K. stocks higher 12:52 p.m. April 28, 2014 - Carla Mozee
Stock futures point to rise as drug stocks rally 9:29 a.m. April 28, 2014 - Sara Sjolin
Allergan cut to hold by Stifel on takeover risks 7:57 a.m. April 28, 2014 - Ben Eisen
Allergan cut to hold from buy at Stifel Research 7:18 a.m. April 28, 2014 - Barbara Kollmeyer
Pfizer steps up $100 billion bid for AstraZeneca 3:53 a.m. April 28, 2014 - MarketWatch.com
$100 billion M&A week is actually good for bondholders: Barclays 2:24 p.m. April 25, 2014 - blogs.marketwatch.com
In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
How to find off the radar stocks 12:07 p.m. April 23, 2014 - blogs.marketwatch.com
Ackman says he's in it for long haul on proposed Valeant-Allergan deal 11:59 a.m. April 23, 2014 - blogs.marketwatch.com
Ackman: Didn't violate insider-trading rules over Allergan 7:58 a.m. April 23, 2014 - Silvia Ascarelli
Ackman: Allergan poison pill lets board explore options 7:42 a.m. April 23, 2014 - Silvia Ascarelli
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Allergan adopts poison pill in face of Valeant bid 3:48 a.m. April 23, 2014 - Liz Hoffman
U.S. stocks gain; S&P 500 extends streak to six 5:14 p.m. April 22, 2014 - Anora Mahmudova
Newscast: Stocks notch another win 4:32 p.m. April 22, 2014 - MarketWatch
S&P 500, Nasdaq extend win streak to 6 sessions: Stock market live blog recap 3:56 p.m. April 22, 2014 - blogs.marketwatch.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. Today - TheStreet.com
Pershing Square L.P. Hedge Fund Gains 7.3% in April 9:13 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
What's With All The Healthcare And Pharmaceutical Mergers? 5:25 p.m. May 1, 2014 - TheStreet.com
Allergan Inc (AGN): Today's Featured Health Care Winner 5:00 p.m. May 1, 2014 - TheStreet.com
Glaxo Misses on Q1 Earnings, Shares Down - Analyst Blog 2:14 p.m. May 1, 2014 - Zacks.com
Shire's Appeal Doesn't Rest on Takeover Attention 1:10 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Shire Raises Earnings Guidance 11:24 a.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Allergan's Options For Fending Off Valeant's Hostile Takeover 7:23 a.m. May 1, 2014 - Seeking Alpha
Novartis' Zykadia Gets FDA Approval - Analyst Blog 6:10 p.m. April 30, 2014 - Zacks.com
Ironwood Up as Loss Narrows, Linzess Shines - Analyst Blog 4:45 p.m. April 30, 2014 - Zacks.com
Will Mylan (MYL) Miss Q1 Earnings? - Analyst Blog 4:26 p.m. April 30, 2014 - Zacks.com
Financial Engineers Hard at Work at Apple, Pfizer 7:40 a.m. April 30, 2014 - Barrons.com
In Drug Mergers, There's One Sure Bet: The Layoffs 7:12 p.m. April 29, 2014 - The Wall Street Journal Interactive Edition
Benzinga's M&A Chatter for Tuesday April 29, 2014 7:07 p.m. April 29, 2014 - benzinga.com
Can Hospira (HSP) Keep the Earnings Streak Alive? - Analyst Blog 5:10 p.m. April 29, 2014 - Zacks.com
Stocks Finish Higher on Solid Earnings 4:14 p.m. April 29, 2014 - TheStreet.com
AstraZeneca Soars as Pfizer Confirms Buyout Talks - Analyst Blog 2:38 p.m. April 29, 2014 - Zacks.com
Icahn And Ackman Kiss And Make Up 12:39 p.m. April 29, 2014 - benzinga.com
Bristol, Merck, Sanofi Report Soft Q1 Sales 11:15 a.m. April 29, 2014 - Investors Business Daily
Allergan Reportedly Seeks Alternate Suitor 9:37 a.m. April 29, 2014 - FOXBusiness
Merger & Acquisition Updates, Quarterly Earnings Releases, and Clinical Trial Results - Analyst Notes on Allergan, Amgen, Furiex, Teva and Alexion 9:00 a.m. May 1, 2014 - PR Newswire - PRF
The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:15 p.m. April 24, 2014 - PR Newswire - PRF
Stock Price Updates, Acquisition Proposals, Upcoming Events, Senior Level Appointments, and Pending Acquisition - Analyst Notes on AstraZeneca, Valeant, WellPoint, Illumina and Forest 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Fitch Places Allergan's Ratings on Negative Watch 3:32 p.m. April 23, 2014 - BusinessWire - BZX
PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 12:30 p.m. April 23, 2014 - PR Newswire - PRF
Critical Alerts For Allergan, SunEdison, Valeant Pharmaceuticals, Shire PLC, and Paychex Released By InvestorsObserver 9:31 a.m. April 23, 2014 - PR Newswire - PRF
Allergan Adopts One-Year Stockholder Rights Plan 8:25 p.m. April 22, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Allergan Inc. over the Proposed Takeover of the Company 11:17 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Confirms Receipt of Unsolicited Proposal from Valeant 11:00 a.m. April 22, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Proposal 10:12 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Notes Public Filings by Valeant and Pershing Square 10:45 p.m. April 21, 2014 - BusinessWire - BZX
Dr. Rian A. Maercks Announces Appointment to Elite ASCENT National Advisory Panel in Plastic Surgery, Comprised of Top 25 Leaders in Innovative Plastic Surgery in the U.S. 8:45 a.m. April 17, 2014 - PR Newswire - PRF
TauTona Group Sells Aline HA(R) to Allergan 8:30 a.m. April 17, 2014 - Marketwire
Global Laparoscopic Devices Industry 4:19 p.m. April 16, 2014 - PR Newswire - PRF
Top-of-Mind Companies in Facial Injectable and Laser/Energy Device Markets Are Similar in Europe and Asia 10:00 a.m. April 15, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on Allergan, Visa, Starbucks, and Home Depot 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Sientra Appoints Charlie Huiner as Chief Strategy and Corporate Development Officer 2:00 p.m. April 8, 2014 - BusinessWire - BZX
U.K. stocks advance, but Shire loses grip of gains 12:29 p.m. April 29, 2014 - Carla Mozee
Allergan looks for white knight to counter Valeant's hostile bid: reports 11:10 a.m. April 29, 2014 - blogs.marketwatch.com
Allergan looks to Sanofi, J&J for takeover: report 9:48 a.m. April 29, 2014 - Karen Friar
Allergan preparing to approach Shire: report 4:23 p.m. April 28, 2014 - MarketWatch.com
AstraZeneca jumps, leading U.K. stocks higher 12:52 p.m. April 28, 2014 - Carla Mozee
Stock futures point to rise as drug stocks rally 9:29 a.m. April 28, 2014 - Sara Sjolin
Allergan cut to hold by Stifel on takeover risks 7:57 a.m. April 28, 2014 - Ben Eisen
Allergan cut to hold from buy at Stifel Research 7:18 a.m. April 28, 2014 - Barbara Kollmeyer
Pfizer steps up $100 billion bid for AstraZeneca 3:53 a.m. April 28, 2014 - MarketWatch.com
$100 billion M&A week is actually good for bondholders: Barclays 2:24 p.m. April 25, 2014 - blogs.marketwatch.com
In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
How to find off the radar stocks 12:07 p.m. April 23, 2014 - blogs.marketwatch.com
Ackman says he's in it for long haul on proposed Valeant-Allergan deal 11:59 a.m. April 23, 2014 - blogs.marketwatch.com
Ackman: Didn't violate insider-trading rules over Allergan 7:58 a.m. April 23, 2014 - Silvia Ascarelli
Ackman: Allergan poison pill lets board explore options 7:42 a.m. April 23, 2014 - Silvia Ascarelli
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Allergan adopts poison pill in face of Valeant bid 3:48 a.m. April 23, 2014 - Liz Hoffman
U.S. stocks gain; S&P 500 extends streak to six 5:14 p.m. April 22, 2014 - Anora Mahmudova
Newscast: Stocks notch another win 4:32 p.m. April 22, 2014 - MarketWatch
S&P 500, Nasdaq extend win streak to 6 sessions: Stock market live blog recap 3:56 p.m. April 22, 2014 - blogs.marketwatch.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. Today - TheStreet.com
Pershing Square L.P. Hedge Fund Gains 7.3% in April 9:13 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
What's With All The Healthcare And Pharmaceutical Mergers? 5:25 p.m. May 1, 2014 - TheStreet.com
Allergan Inc (AGN): Today's Featured Health Care Winner 5:00 p.m. May 1, 2014 - TheStreet.com
Glaxo Misses on Q1 Earnings, Shares Down - Analyst Blog 2:14 p.m. May 1, 2014 - Zacks.com
Shire's Appeal Doesn't Rest on Takeover Attention 1:10 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Shire Raises Earnings Guidance 11:24 a.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Allergan's Options For Fending Off Valeant's Hostile Takeover 7:23 a.m. May 1, 2014 - Seeking Alpha
Novartis' Zykadia Gets FDA Approval - Analyst Blog 6:10 p.m. April 30, 2014 - Zacks.com
Ironwood Up as Loss Narrows, Linzess Shines - Analyst Blog 4:45 p.m. April 30, 2014 - Zacks.com
Will Mylan (MYL) Miss Q1 Earnings? - Analyst Blog 4:26 p.m. April 30, 2014 - Zacks.com
Financial Engineers Hard at Work at Apple, Pfizer 7:40 a.m. April 30, 2014 - Barrons.com
In Drug Mergers, There's One Sure Bet: The Layoffs 7:12 p.m. April 29, 2014 - The Wall Street Journal Interactive Edition
Benzinga's M&A Chatter for Tuesday April 29, 2014 7:07 p.m. April 29, 2014 - benzinga.com
Can Hospira (HSP) Keep the Earnings Streak Alive? - Analyst Blog 5:10 p.m. April 29, 2014 - Zacks.com
Stocks Finish Higher on Solid Earnings 4:14 p.m. April 29, 2014 - TheStreet.com
AstraZeneca Soars as Pfizer Confirms Buyout Talks - Analyst Blog 2:38 p.m. April 29, 2014 - Zacks.com
Icahn And Ackman Kiss And Make Up 12:39 p.m. April 29, 2014 - benzinga.com
Bristol, Merck, Sanofi Report Soft Q1 Sales 11:15 a.m. April 29, 2014 - Investors Business Daily
Allergan Reportedly Seeks Alternate Suitor 9:37 a.m. April 29, 2014 - FOXBusiness
Merger & Acquisition Updates, Quarterly Earnings Releases, and Clinical Trial Results - Analyst Notes on Allergan, Amgen, Furiex, Teva and Alexion 9:00 a.m. May 1, 2014 - PR Newswire - PRF
The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:15 p.m. April 24, 2014 - PR Newswire - PRF
Stock Price Updates, Acquisition Proposals, Upcoming Events, Senior Level Appointments, and Pending Acquisition - Analyst Notes on AstraZeneca, Valeant, WellPoint, Illumina and Forest 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Fitch Places Allergan's Ratings on Negative Watch 3:32 p.m. April 23, 2014 - BusinessWire - BZX
PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 12:30 p.m. April 23, 2014 - PR Newswire - PRF
Critical Alerts For Allergan, SunEdison, Valeant Pharmaceuticals, Shire PLC, and Paychex Released By InvestorsObserver 9:31 a.m. April 23, 2014 - PR Newswire - PRF
Allergan Adopts One-Year Stockholder Rights Plan 8:25 p.m. April 22, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Allergan Inc. over the Proposed Takeover of the Company 11:17 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Confirms Receipt of Unsolicited Proposal from Valeant 11:00 a.m. April 22, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Proposal 10:12 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Notes Public Filings by Valeant and Pershing Square 10:45 p.m. April 21, 2014 - BusinessWire - BZX
Dr. Rian A. Maercks Announces Appointment to Elite ASCENT National Advisory Panel in Plastic Surgery, Comprised of Top 25 Leaders in Innovative Plastic Surgery in the U.S. 8:45 a.m. April 17, 2014 - PR Newswire - PRF
TauTona Group Sells Aline HA(R) to Allergan 8:30 a.m. April 17, 2014 - Marketwire
Global Laparoscopic Devices Industry 4:19 p.m. April 16, 2014 - PR Newswire - PRF
Top-of-Mind Companies in Facial Injectable and Laser/Energy Device Markets Are Similar in Europe and Asia 10:00 a.m. April 15, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on Allergan, Visa, Starbucks, and Home Depot 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Sientra Appoints Charlie Huiner as Chief Strategy and Corporate Development Officer 2:00 p.m. April 8, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼